Skip to main content Help with accessibility Skip to main navigation

Budesonide orodispersible tablets (Jorveza®) for induction and maintenance of remission in eosinophilic oesophagitis in adults

CCG Approval Status:

Ha
Kn
Li
SF
SS
SH
Wa
WL
Wi
Date Added: 26 - Sep - 2024
Body System:
Amber retained
Budesonide orodispersible tablets (Jorveza®) for induction and maintenance of remission in eosinophilic oesophagitis in adults

The Cheshire and Merseyside Area Prescribing Group recommends the prescribing of budesonide orodispersible tablets (Jorveza®), with specialist initiation, for induction and maintenance of remission in eosinophilic oesophagitis in adults.

NHS Cheshire and Merseyside APPROVED